nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—PTGS1—Etoposide—muscle cancer	0.18	0.261	CbGbCtD
Terbinafine—CYP1A2—Dacarbazine—muscle cancer	0.164	0.238	CbGbCtD
Terbinafine—CYP2C8—Etoposide—muscle cancer	0.104	0.15	CbGbCtD
Terbinafine—CYP1A2—Etoposide—muscle cancer	0.0805	0.116	CbGbCtD
Terbinafine—CYP3A4—Vincristine—muscle cancer	0.046	0.0666	CbGbCtD
Terbinafine—CYP2D6—Doxorubicin—muscle cancer	0.0452	0.0654	CbGbCtD
Terbinafine—CYP3A4—Etoposide—muscle cancer	0.0422	0.061	CbGbCtD
Terbinafine—CYP3A4—Doxorubicin—muscle cancer	0.0288	0.0416	CbGbCtD
Terbinafine—Jaundice—Etoposide—muscle cancer	0.00141	0.00455	CcSEcCtD
Terbinafine—Malaise—Dactinomycin—muscle cancer	0.0014	0.00454	CcSEcCtD
Terbinafine—Mental disorder—Vincristine—muscle cancer	0.0014	0.00453	CcSEcCtD
Terbinafine—Hepatobiliary disease—Etoposide—muscle cancer	0.00136	0.00441	CcSEcCtD
Terbinafine—Agranulocytosis—Etoposide—muscle cancer	0.00135	0.00435	CcSEcCtD
Terbinafine—Hepatocellular injury—Doxorubicin—muscle cancer	0.00134	0.00433	CcSEcCtD
Terbinafine—Myalgia—Dactinomycin—muscle cancer	0.00133	0.00429	CcSEcCtD
Terbinafine—Dermatitis contact—Doxorubicin—muscle cancer	0.00132	0.00427	CcSEcCtD
Terbinafine—Eructation—Doxorubicin—muscle cancer	0.00131	0.00425	CcSEcCtD
Terbinafine—Discomfort—Dactinomycin—muscle cancer	0.00131	0.00424	CcSEcCtD
Terbinafine—Influenza like illness—Doxorubicin—muscle cancer	0.0013	0.0042	CcSEcCtD
Terbinafine—Hypoaesthesia—Etoposide—muscle cancer	0.00129	0.00417	CcSEcCtD
Terbinafine—Anaemia—Vincristine—muscle cancer	0.00129	0.00416	CcSEcCtD
Terbinafine—Photosensitivity—Methotrexate—muscle cancer	0.00128	0.00413	CcSEcCtD
Terbinafine—Skin exfoliation—Doxorubicin—muscle cancer	0.00128	0.00413	CcSEcCtD
Terbinafine—Infection—Dactinomycin—muscle cancer	0.00126	0.00408	CcSEcCtD
Terbinafine—Blood urea increased—Doxorubicin—muscle cancer	0.00126	0.00408	CcSEcCtD
Terbinafine—Vertigo—Vincristine—muscle cancer	0.00125	0.00404	CcSEcCtD
Terbinafine—Hepatic failure—Methotrexate—muscle cancer	0.00125	0.00404	CcSEcCtD
Terbinafine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00124	0.00403	CcSEcCtD
Terbinafine—Erythema multiforme—Etoposide—muscle cancer	0.00122	0.00396	CcSEcCtD
Terbinafine—Anorexia—Dactinomycin—muscle cancer	0.00121	0.00392	CcSEcCtD
Terbinafine—Eye disorder—Etoposide—muscle cancer	0.00121	0.00391	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00119	0.00384	CcSEcCtD
Terbinafine—Myalgia—Vincristine—muscle cancer	0.00118	0.00383	CcSEcCtD
Terbinafine—Visual disturbance—Methotrexate—muscle cancer	0.00118	0.00383	CcSEcCtD
Terbinafine—Angiopathy—Etoposide—muscle cancer	0.00117	0.0038	CcSEcCtD
Terbinafine—Immune system disorder—Etoposide—muscle cancer	0.00117	0.00378	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00116	0.00375	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00116	0.00375	CcSEcCtD
Terbinafine—Alopecia—Etoposide—muscle cancer	0.00114	0.0037	CcSEcCtD
Terbinafine—Anaphylactic shock—Vincristine—muscle cancer	0.00114	0.00367	CcSEcCtD
Terbinafine—Infection—Vincristine—muscle cancer	0.00113	0.00365	CcSEcCtD
Terbinafine—Nervous system disorder—Vincristine—muscle cancer	0.00111	0.0036	CcSEcCtD
Terbinafine—Thrombocytopenia—Vincristine—muscle cancer	0.00111	0.0036	CcSEcCtD
Terbinafine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00111	0.00359	CcSEcCtD
Terbinafine—Photosensitivity—Doxorubicin—muscle cancer	0.0011	0.00358	CcSEcCtD
Terbinafine—Decreased appetite—Dactinomycin—muscle cancer	0.0011	0.00357	CcSEcCtD
Terbinafine—Dysgeusia—Etoposide—muscle cancer	0.0011	0.00357	CcSEcCtD
Terbinafine—Fatigue—Dactinomycin—muscle cancer	0.0011	0.00354	CcSEcCtD
Terbinafine—Pain—Dactinomycin—muscle cancer	0.00109	0.00352	CcSEcCtD
Terbinafine—Muscle spasms—Etoposide—muscle cancer	0.00108	0.00351	CcSEcCtD
Terbinafine—Anorexia—Vincristine—muscle cancer	0.00108	0.0035	CcSEcCtD
Terbinafine—Eczema—Doxorubicin—muscle cancer	0.00108	0.00349	CcSEcCtD
Terbinafine—Hepatic failure—Doxorubicin—muscle cancer	0.00108	0.00349	CcSEcCtD
Terbinafine—Feeling abnormal—Dactinomycin—muscle cancer	0.00105	0.00339	CcSEcCtD
Terbinafine—Ill-defined disorder—Etoposide—muscle cancer	0.00105	0.00338	CcSEcCtD
Terbinafine—Anaemia—Etoposide—muscle cancer	0.00104	0.00337	CcSEcCtD
Terbinafine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00104	0.00336	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00103	0.00335	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00103	0.00333	CcSEcCtD
Terbinafine—Paraesthesia—Vincristine—muscle cancer	0.00102	0.0033	CcSEcCtD
Terbinafine—Malaise—Etoposide—muscle cancer	0.00102	0.00329	CcSEcCtD
Terbinafine—Dermatitis bullous—Doxorubicin—muscle cancer	0.00102	0.00329	CcSEcCtD
Terbinafine—Vertigo—Etoposide—muscle cancer	0.00101	0.00328	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00101	0.00327	CcSEcCtD
Terbinafine—Body temperature increased—Dactinomycin—muscle cancer	0.001	0.00325	CcSEcCtD
Terbinafine—Abdominal pain—Dactinomycin—muscle cancer	0.001	0.00325	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.001	0.00324	CcSEcCtD
Terbinafine—Hypoglycaemia—Doxorubicin—muscle cancer	0.000994	0.00322	CcSEcCtD
Terbinafine—Decreased appetite—Vincristine—muscle cancer	0.000987	0.00319	CcSEcCtD
Terbinafine—Cough—Etoposide—muscle cancer	0.000983	0.00318	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00098	0.00317	CcSEcCtD
Terbinafine—Fatigue—Vincristine—muscle cancer	0.000979	0.00317	CcSEcCtD
Terbinafine—Pain—Vincristine—muscle cancer	0.000971	0.00314	CcSEcCtD
Terbinafine—Chest pain—Etoposide—muscle cancer	0.000959	0.0031	CcSEcCtD
Terbinafine—Eosinophilia—Methotrexate—muscle cancer	0.000959	0.0031	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000953	0.00308	CcSEcCtD
Terbinafine—Pancreatitis—Methotrexate—muscle cancer	0.00095	0.00307	CcSEcCtD
Terbinafine—Discomfort—Etoposide—muscle cancer	0.000948	0.00307	CcSEcCtD
Terbinafine—Hypersensitivity—Dactinomycin—muscle cancer	0.000936	0.00303	CcSEcCtD
Terbinafine—Abdominal discomfort—Methotrexate—muscle cancer	0.000928	0.003	CcSEcCtD
Terbinafine—Gastrointestinal pain—Vincristine—muscle cancer	0.000928	0.003	CcSEcCtD
Terbinafine—Confusional state—Etoposide—muscle cancer	0.000927	0.003	CcSEcCtD
Terbinafine—Pancytopenia—Methotrexate—muscle cancer	0.00092	0.00298	CcSEcCtD
Terbinafine—Anaphylactic shock—Etoposide—muscle cancer	0.000919	0.00298	CcSEcCtD
Terbinafine—Infection—Etoposide—muscle cancer	0.000913	0.00296	CcSEcCtD
Terbinafine—Asthenia—Dactinomycin—muscle cancer	0.000911	0.00295	CcSEcCtD
Terbinafine—Neutropenia—Methotrexate—muscle cancer	0.000906	0.00293	CcSEcCtD
Terbinafine—Thrombocytopenia—Etoposide—muscle cancer	0.0009	0.00291	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.0009	0.00291	CcSEcCtD
Terbinafine—Body temperature increased—Vincristine—muscle cancer	0.000897	0.0029	CcSEcCtD
Terbinafine—Abdominal pain—Vincristine—muscle cancer	0.000897	0.0029	CcSEcCtD
Terbinafine—Skin disorder—Etoposide—muscle cancer	0.000893	0.00289	CcSEcCtD
Terbinafine—Abdominal pain upper—Doxorubicin—muscle cancer	0.000886	0.00287	CcSEcCtD
Terbinafine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000884	0.00286	CcSEcCtD
Terbinafine—Anorexia—Etoposide—muscle cancer	0.000876	0.00284	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000874	0.00283	CcSEcCtD
Terbinafine—Diarrhoea—Dactinomycin—muscle cancer	0.000869	0.00281	CcSEcCtD
Terbinafine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000868	0.00281	CcSEcCtD
Terbinafine—Infestation NOS—Methotrexate—muscle cancer	0.000864	0.00279	CcSEcCtD
Terbinafine—Infestation—Methotrexate—muscle cancer	0.000864	0.00279	CcSEcCtD
Terbinafine—Gastritis—Doxorubicin—muscle cancer	0.000859	0.00278	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000856	0.00277	CcSEcCtD
Terbinafine—Influenza—Doxorubicin—muscle cancer	0.000839	0.00271	CcSEcCtD
Terbinafine—Hypersensitivity—Vincristine—muscle cancer	0.000836	0.00271	CcSEcCtD
Terbinafine—Eosinophilia—Doxorubicin—muscle cancer	0.00083	0.00269	CcSEcCtD
Terbinafine—Paraesthesia—Etoposide—muscle cancer	0.000826	0.00267	CcSEcCtD
Terbinafine—Pancreatitis—Doxorubicin—muscle cancer	0.000822	0.00266	CcSEcCtD
Terbinafine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000817	0.00264	CcSEcCtD
Terbinafine—Asthenia—Vincristine—muscle cancer	0.000814	0.00264	CcSEcCtD
Terbinafine—Vomiting—Dactinomycin—muscle cancer	0.000808	0.00261	CcSEcCtD
Terbinafine—Agranulocytosis—Methotrexate—muscle cancer	0.000806	0.00261	CcSEcCtD
Terbinafine—Rash—Dactinomycin—muscle cancer	0.000801	0.00259	CcSEcCtD
Terbinafine—Decreased appetite—Etoposide—muscle cancer	0.000799	0.00259	CcSEcCtD
Terbinafine—Pancytopenia—Doxorubicin—muscle cancer	0.000796	0.00258	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000794	0.00257	CcSEcCtD
Terbinafine—Fatigue—Etoposide—muscle cancer	0.000793	0.00257	CcSEcCtD
Terbinafine—Pain—Etoposide—muscle cancer	0.000786	0.00254	CcSEcCtD
Terbinafine—Neutropenia—Doxorubicin—muscle cancer	0.000784	0.00254	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000779	0.00252	CcSEcCtD
Terbinafine—Diarrhoea—Vincristine—muscle cancer	0.000777	0.00251	CcSEcCtD
Terbinafine—Hepatitis—Methotrexate—muscle cancer	0.000775	0.00251	CcSEcCtD
Terbinafine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000765	0.00248	CcSEcCtD
Terbinafine—Weight decreased—Doxorubicin—muscle cancer	0.000759	0.00246	CcSEcCtD
Terbinafine—Feeling abnormal—Etoposide—muscle cancer	0.000758	0.00245	CcSEcCtD
Terbinafine—Nausea—Dactinomycin—muscle cancer	0.000755	0.00244	CcSEcCtD
Terbinafine—Gastrointestinal pain—Etoposide—muscle cancer	0.000752	0.00243	CcSEcCtD
Terbinafine—Dizziness—Vincristine—muscle cancer	0.000751	0.00243	CcSEcCtD
Terbinafine—Infestation NOS—Doxorubicin—muscle cancer	0.000748	0.00242	CcSEcCtD
Terbinafine—Infestation—Doxorubicin—muscle cancer	0.000748	0.00242	CcSEcCtD
Terbinafine—Visual impairment—Methotrexate—muscle cancer	0.000747	0.00242	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000741	0.0024	CcSEcCtD
Terbinafine—Erythema multiforme—Methotrexate—muscle cancer	0.000733	0.00237	CcSEcCtD
Terbinafine—Urticaria—Etoposide—muscle cancer	0.00073	0.00236	CcSEcCtD
Terbinafine—Jaundice—Doxorubicin—muscle cancer	0.000729	0.00236	CcSEcCtD
Terbinafine—Abdominal pain—Etoposide—muscle cancer	0.000727	0.00235	CcSEcCtD
Terbinafine—Body temperature increased—Etoposide—muscle cancer	0.000727	0.00235	CcSEcCtD
Terbinafine—Eye disorder—Methotrexate—muscle cancer	0.000724	0.00234	CcSEcCtD
Terbinafine—Tinnitus—Methotrexate—muscle cancer	0.000723	0.00234	CcSEcCtD
Terbinafine—Vomiting—Vincristine—muscle cancer	0.000722	0.00234	CcSEcCtD
Terbinafine—Rash—Vincristine—muscle cancer	0.000716	0.00232	CcSEcCtD
Terbinafine—Dermatitis—Vincristine—muscle cancer	0.000715	0.00231	CcSEcCtD
Terbinafine—Headache—Vincristine—muscle cancer	0.000711	0.0023	CcSEcCtD
Terbinafine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000707	0.00229	CcSEcCtD
Terbinafine—Angiopathy—Methotrexate—muscle cancer	0.000703	0.00228	CcSEcCtD
Terbinafine—Immune system disorder—Methotrexate—muscle cancer	0.0007	0.00227	CcSEcCtD
Terbinafine—Agranulocytosis—Doxorubicin—muscle cancer	0.000698	0.00226	CcSEcCtD
Terbinafine—Alopecia—Methotrexate—muscle cancer	0.000685	0.00222	CcSEcCtD
Terbinafine—Mental disorder—Methotrexate—muscle cancer	0.000679	0.0022	CcSEcCtD
Terbinafine—Hypersensitivity—Etoposide—muscle cancer	0.000677	0.00219	CcSEcCtD
Terbinafine—Erythema—Methotrexate—muscle cancer	0.000675	0.00218	CcSEcCtD
Terbinafine—Nausea—Vincristine—muscle cancer	0.000674	0.00218	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—muscle cancer	0.000671	0.00217	CcSEcCtD
Terbinafine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000668	0.00216	CcSEcCtD
Terbinafine—Dysgeusia—Methotrexate—muscle cancer	0.000661	0.00214	CcSEcCtD
Terbinafine—Asthenia—Etoposide—muscle cancer	0.00066	0.00213	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—muscle cancer	0.00066	0.00213	CcSEcCtD
Terbinafine—Pruritus—Etoposide—muscle cancer	0.00065	0.00211	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—muscle cancer	0.000647	0.00209	CcSEcCtD
Terbinafine—Vision blurred—Methotrexate—muscle cancer	0.000636	0.00206	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—muscle cancer	0.000635	0.00205	CcSEcCtD
Terbinafine—Diarrhoea—Etoposide—muscle cancer	0.000629	0.00204	CcSEcCtD
Terbinafine—Eye disorder—Doxorubicin—muscle cancer	0.000627	0.00203	CcSEcCtD
Terbinafine—Ill-defined disorder—Methotrexate—muscle cancer	0.000626	0.00203	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—muscle cancer	0.000626	0.00203	CcSEcCtD
Terbinafine—Anaemia—Methotrexate—muscle cancer	0.000624	0.00202	CcSEcCtD
Terbinafine—Angiopathy—Doxorubicin—muscle cancer	0.000609	0.00197	CcSEcCtD
Terbinafine—Malaise—Methotrexate—muscle cancer	0.000609	0.00197	CcSEcCtD
Terbinafine—Dizziness—Etoposide—muscle cancer	0.000608	0.00197	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—muscle cancer	0.000606	0.00196	CcSEcCtD
Terbinafine—Vertigo—Methotrexate—muscle cancer	0.000606	0.00196	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—muscle cancer	0.000593	0.00192	CcSEcCtD
Terbinafine—Cough—Methotrexate—muscle cancer	0.000589	0.00191	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—muscle cancer	0.000588	0.0019	CcSEcCtD
Terbinafine—Vomiting—Etoposide—muscle cancer	0.000585	0.00189	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—muscle cancer	0.000584	0.00189	CcSEcCtD
Terbinafine—Rash—Etoposide—muscle cancer	0.00058	0.00188	CcSEcCtD
Terbinafine—Dermatitis—Etoposide—muscle cancer	0.000579	0.00187	CcSEcCtD
Terbinafine—Headache—Etoposide—muscle cancer	0.000576	0.00186	CcSEcCtD
Terbinafine—Flatulence—Doxorubicin—muscle cancer	0.000576	0.00186	CcSEcCtD
Terbinafine—Chest pain—Methotrexate—muscle cancer	0.000574	0.00186	CcSEcCtD
Terbinafine—Myalgia—Methotrexate—muscle cancer	0.000574	0.00186	CcSEcCtD
Terbinafine—Arthralgia—Methotrexate—muscle cancer	0.000574	0.00186	CcSEcCtD
Terbinafine—Dysgeusia—Doxorubicin—muscle cancer	0.000572	0.00185	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000571	0.00185	CcSEcCtD
Terbinafine—Discomfort—Methotrexate—muscle cancer	0.000568	0.00184	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—muscle cancer	0.000562	0.00182	CcSEcCtD
Terbinafine—Confusional state—Methotrexate—muscle cancer	0.000555	0.0018	CcSEcCtD
Terbinafine—Anaphylactic shock—Methotrexate—muscle cancer	0.000551	0.00178	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—muscle cancer	0.000551	0.00178	CcSEcCtD
Terbinafine—Infection—Methotrexate—muscle cancer	0.000547	0.00177	CcSEcCtD
Terbinafine—Nausea—Etoposide—muscle cancer	0.000546	0.00177	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000542	0.00175	CcSEcCtD
Terbinafine—Nervous system disorder—Methotrexate—muscle cancer	0.00054	0.00175	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—muscle cancer	0.00054	0.00175	CcSEcCtD
Terbinafine—Thrombocytopenia—Methotrexate—muscle cancer	0.000539	0.00175	CcSEcCtD
Terbinafine—Skin disorder—Methotrexate—muscle cancer	0.000535	0.00173	CcSEcCtD
Terbinafine—Malaise—Doxorubicin—muscle cancer	0.000527	0.00171	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—muscle cancer	0.000525	0.0017	CcSEcCtD
Terbinafine—Anorexia—Methotrexate—muscle cancer	0.000525	0.0017	CcSEcCtD
Terbinafine—Cough—Doxorubicin—muscle cancer	0.00051	0.00165	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000502	0.00162	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—muscle cancer	0.000497	0.00161	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—muscle cancer	0.000497	0.00161	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—muscle cancer	0.000497	0.00161	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—muscle cancer	0.000496	0.0016	CcSEcCtD
Terbinafine—Paraesthesia—Methotrexate—muscle cancer	0.000495	0.0016	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000494	0.0016	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—muscle cancer	0.000491	0.00159	CcSEcCtD
Terbinafine—Dry mouth—Doxorubicin—muscle cancer	0.000487	0.00157	CcSEcCtD
Terbinafine—Dyspepsia—Methotrexate—muscle cancer	0.000485	0.00157	CcSEcCtD
Terbinafine—Confusional state—Doxorubicin—muscle cancer	0.000481	0.00156	CcSEcCtD
Terbinafine—Decreased appetite—Methotrexate—muscle cancer	0.000479	0.00155	CcSEcCtD
Terbinafine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000477	0.00154	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000475	0.00154	CcSEcCtD
Terbinafine—Fatigue—Methotrexate—muscle cancer	0.000475	0.00154	CcSEcCtD
Terbinafine—Infection—Doxorubicin—muscle cancer	0.000474	0.00153	CcSEcCtD
Terbinafine—Pain—Methotrexate—muscle cancer	0.000471	0.00152	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—muscle cancer	0.000468	0.00151	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000467	0.00151	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—muscle cancer	0.000463	0.0015	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—muscle cancer	0.000455	0.00147	CcSEcCtD
Terbinafine—Feeling abnormal—Methotrexate—muscle cancer	0.000454	0.00147	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00045	0.00146	CcSEcCtD
Terbinafine—Urticaria—Methotrexate—muscle cancer	0.000438	0.00142	CcSEcCtD
Terbinafine—Abdominal pain—Methotrexate—muscle cancer	0.000435	0.00141	CcSEcCtD
Terbinafine—Body temperature increased—Methotrexate—muscle cancer	0.000435	0.00141	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000434	0.00141	CcSEcCtD
Terbinafine—Paraesthesia—Doxorubicin—muscle cancer	0.000428	0.00139	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—muscle cancer	0.00042	0.00136	CcSEcCtD
Terbinafine—Decreased appetite—Doxorubicin—muscle cancer	0.000415	0.00134	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000412	0.00133	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—muscle cancer	0.000411	0.00133	CcSEcCtD
Terbinafine—Pain—Doxorubicin—muscle cancer	0.000408	0.00132	CcSEcCtD
Terbinafine—Hypersensitivity—Methotrexate—muscle cancer	0.000406	0.00131	CcSEcCtD
Terbinafine—Asthenia—Methotrexate—muscle cancer	0.000395	0.00128	CcSEcCtD
Terbinafine—Feeling abnormal—Doxorubicin—muscle cancer	0.000393	0.00127	CcSEcCtD
Terbinafine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00039	0.00126	CcSEcCtD
Terbinafine—Pruritus—Methotrexate—muscle cancer	0.00039	0.00126	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—muscle cancer	0.000379	0.00123	CcSEcCtD
Terbinafine—Abdominal pain—Doxorubicin—muscle cancer	0.000377	0.00122	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—muscle cancer	0.000377	0.00122	CcSEcCtD
Terbinafine—Diarrhoea—Methotrexate—muscle cancer	0.000377	0.00122	CcSEcCtD
Terbinafine—Dizziness—Methotrexate—muscle cancer	0.000364	0.00118	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—muscle cancer	0.000351	0.00114	CcSEcCtD
Terbinafine—Vomiting—Methotrexate—muscle cancer	0.00035	0.00113	CcSEcCtD
Terbinafine—Rash—Methotrexate—muscle cancer	0.000347	0.00112	CcSEcCtD
Terbinafine—Dermatitis—Methotrexate—muscle cancer	0.000347	0.00112	CcSEcCtD
Terbinafine—Headache—Methotrexate—muscle cancer	0.000345	0.00112	CcSEcCtD
Terbinafine—Asthenia—Doxorubicin—muscle cancer	0.000342	0.00111	CcSEcCtD
Terbinafine—Pruritus—Doxorubicin—muscle cancer	0.000337	0.00109	CcSEcCtD
Terbinafine—Nausea—Methotrexate—muscle cancer	0.000327	0.00106	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—muscle cancer	0.000326	0.00106	CcSEcCtD
Terbinafine—Dizziness—Doxorubicin—muscle cancer	0.000315	0.00102	CcSEcCtD
Terbinafine—Vomiting—Doxorubicin—muscle cancer	0.000303	0.000981	CcSEcCtD
Terbinafine—Rash—Doxorubicin—muscle cancer	0.000301	0.000973	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—muscle cancer	0.0003	0.000972	CcSEcCtD
Terbinafine—Headache—Doxorubicin—muscle cancer	0.000299	0.000967	CcSEcCtD
Terbinafine—Nausea—Doxorubicin—muscle cancer	0.000283	0.000917	CcSEcCtD
